Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 239

1.

Evidence of dose-response following hypofractionated stereotactic radiotherapy to the cavity after surgery for brain metastases.

Garimall S, Shanker M, Johns E, Watkins T, Olson S, Huo M, Foote MC, Pinkham MB.

J Neurooncol. 2020 Jan 6. doi: 10.1007/s11060-019-03383-w. [Epub ahead of print]

PMID:
31907796
2.

Efficient Silver Release From Ion Exchange Silver Dressings in Biologically Relevant Media.

Mondal R, Foote M, Canada A, Wiencek M, Cowan ME, Acevedo C.

Wounds. 2019 Oct 31. pii: WNDS20191019-1. [Epub ahead of print]

3.

Extent of surrounding edema does not correlate with acute complications after radiosurgery for melanoma brain metastases.

Jardim A, Scott J, Drew Z, Foote MC, Sadasivan AP, Hall B, Olson SL, Shanker M, Pinkham MB.

J Neurooncol. 2019 Dec;145(3):581-585. doi: 10.1007/s11060-019-03330-9. Epub 2019 Nov 5.

PMID:
31691060
4.

Identification of Racial Inequities in Access to Specialized Inpatient Heart Failure Care at an Academic Medical Center.

Eberly LA, Richterman A, Beckett AG, Wispelwey B, Marsh RH, Cleveland Manchanda EC, Chang CY, Glynn RJ, Brooks KC, Boxer R, Kakoza R, Goldsmith J, Loscalzo J, Morse M, Lewis EF, Abel S, Adams A, Anaya J, Andrews EH, Atkinson B, Avutu V, Bachorik A, Badri O, Bailey M, Baird K, Bakshi S, Balaban D, Barshop K, Baumrin E, Bayomy O, Beamesderfer J, Becker N, Berg DD, Berman AN, Blum SM, Boardman AP, Boden K, Bonacci RA, Brown S, Campbell K, Case S, Cetrone E, Charrow A, Chiang D, Clark D, Cohen AJ, Cooper A, Cordova T, Cuneo CN, de Feria AA, Deffenbacher K, DeFilippis EM, DeGregorio G, Deutsch AJ, Diephuis B, Divakaran S, Dorschner P, Downing N, Drescher C, D'Silva KM, Dunbar P, Duong D, Earp S, Eckhardt C, Elman SA, England R, Everett K, Fedotova N, Feingold-Link T, Ferreira M, Fisher H, Foo P, Foote M, Franco I, Gilliland T, Greb J, Greco K, Grewal S, Grin B, Growdon ME, Guercio B, Hahn CK, Hasselfeld B, Haydu EJ, Hermes Z, Hildick-Smith G, Holcomb Z, Holroyd K, Horton L, Huang G, Jablonski S, Jacobs D, Jain N, Japa S, Joseph R, Kalashnikova M, Kalwani N, Kang D, Karan A, Katz JT, Kellner D, Kidia K, Kim JH, Knowles SM, Kolbe L, Kore I, Koullias Y, Kuye I, Lang J, Lawlor M, Lechner MG, Lee K, Lee S, Lee Z, Limaye N, Lin-Beckford S, Lipsyc M, Little J, Loewenthal J, Logaraj R, Lopez DM, Loriaux D, Lu Y, Ma K, Marukian N, Matias W, Mayers JR, McConnell I, McLaughlin M, Meade C, Meador C, Mehta A, Messenger E, Michaelidis C, Mirsky J, Mitten E, Mueller A, Mullur J, Munir A, Murphy E, Nagami E, Natarajan A, Nsahlai M, Nze C, Okwara N, Olds P, Paez R, Pardo M, Patel S, Petersen A, Phelan L, Pimenta E, Pipilas D, Plovanich M, Pong D, Powers BW, Rao A, Ramirez Batlle H, Ramsis M, Reichardt A, Reiger S, Rengarajan M, Rico S, Rome BN, Rosales R, Rotenstein L, Roy A, Royston S, Rozansky H, Rudder M, Ryan CE, Salgado S, Sanchez P, Schulte J, Sekar A, Semenkovich N, Shannon E, Shaw N, Shorten AB, Shrauner W, Sinnenberg L, Smithy JW, Snyder G, Sreekrishnan A, Stabenau H, Stavrou E, Stergachis A, Stern R, Stone A, Tabrizi S, Tanyos S, Thomas C, Thun H, Torres-Lockhart K, Tran A, Treasure C, Tsai FD, Tsaur S, Tschirhart E, Tuwatananurak J, Venkateswaran RV, Vishnevetsky A, Wahl L, Wall A, Wallace F, Walsh E, Wang P, Ward HB, Warner LN, Weeks LD, Weiskopf K, Wengrod J, Williams JN, Winkler M, Wong JL, Worster D, Wright A, Wunsch C, Wynter JS, Yarbrough C, Yau WY, Yazdi D, Yeh J, Yialamas MA, Yozamp N, Zambrotta M, Zon R.

Circ Heart Fail. 2019 Nov;12(11):e006214. doi: 10.1161/CIRCHEARTFAILURE.119.006214. Epub 2019 Oct 29.

PMID:
31658831
5.

Commentary: Postoperative Stereotactic Body Radiotherapy for Spinal Metastases and the Impact of Epidural Disease Grade.

Vellayappan B, Kumar N, Foote M, Hofstetter CP, Saigal R, Chao ST, Lo SS.

Neurosurgery. 2020 Jan 1;86(1):E91-E92. doi: 10.1093/neuros/nyz433. No abstract available.

PMID:
31595964
6.

The Element of Surprise.

Vallurupalli M, Vaidya A, Foote M, Jain N, Parnes A.

N Engl J Med. 2019 Sep 26;381(13):e28. doi: 10.1056/NEJMimc1814675. No abstract available.

PMID:
31553840
7.

Development and prospective in-patient proof-of-concept validation of a surface photogrammetry + CT-based volumetric motion model for lung radiotherapy.

Ranjbar M, Sabouri P, Mossahebi S, Leiser D, Foote M, Zhang J, Lasio G, Joshi S, Sawant A.

Med Phys. 2019 Dec;46(12):5407-5420. doi: 10.1002/mp.13824. Epub 2019 Oct 25.

8.

Coagulation factor activity in units of leukoreduced and nonleukoreduced canine fresh-frozen plasma.

Foote ML, Brooks MB, Archer TM, Wills RW, Mackin AJ, Thomason JM.

Am J Vet Res. 2019 Sep;80(9):846-851. doi: 10.2460/ajvr.80.9.846.

PMID:
31449444
9.

Use of "Doctor" Badges for Physician Role Identification During Clinical Training.

Foote MB, DeFilippis EM, Rome BN, Divakaran S, Yialamas MA.

JAMA Intern Med. 2019 Aug 26. doi: 10.1001/jamainternmed.2019.2416. [Epub ahead of print] No abstract available.

PMID:
31449282
10.

Inhibition of Aurora A Kinase in Combination with Chemotherapy Induces Synthetic Lethality and Overcomes Chemoresistance in Myc-Overexpressing Lymphoma.

Park SI, Lin CP, Ren N, Angus SP, Dittmer DP, Foote M, Parton T, Bhatt AP, Fedoriw YD, Roth DP, Cann ML, Johnson GL, Damania B.

Target Oncol. 2019 Oct;14(5):563-575. doi: 10.1007/s11523-019-00662-4.

PMID:
31429028
11.

Re-irradiation for recurrent high-grade gliomas: a systematic review and analysis of treatment technique with respect to survival and risk of radionecrosis.

Shanker M, Chua B, Bettington C, Foote MC, Pinkham MB.

Neurooncol Pract. 2019 Mar;6(2):144-155. doi: 10.1093/nop/npy019. Epub 2018 Jun 14.

PMID:
31386038
12.

Subjective cognitive functioning and associations with psychological distress in adult brain tumour survivors.

Nicol C, Ownsworth T, Cubis L, Nguyen W, Foote M, Pinkham MB.

J Cancer Surviv. 2019 Oct;13(5):653-662. doi: 10.1007/s11764-019-00784-8. Epub 2019 Jul 17.

PMID:
31313128
13.

Evaluation of a telehealth psychological support intervention for people with primary brain tumour and their family members: Study protocol for a randomised controlled trial.

Ownsworth T, Chambers S, Aitken JF, Foote M, Pinkham MB, Gordon LG, Lock G, Hanley B, Gardner T, Jones S, Robertson J, Shum D, Conlon E.

Eur J Cancer Care (Engl). 2019 Jul;28(4):e13132. doi: 10.1111/ecc.13132. Epub 2019 Jul 10.

PMID:
31293057
14.

Strategies to Mitigate Toxicities From Stereotactic Body Radiation Therapy for Spine Metastases.

Schaub SK, Tseng YD, Chang EL, Sahgal A, Saigal R, Hofstetter CP, Foote M, Ko AL, Yuh WTC, Mossa-Basha M, Mayr NA, Lo SS.

Neurosurgery. 2019 Dec 1;85(6):729-740. doi: 10.1093/neuros/nyz213.

PMID:
31264703
15.

Commentary: Image-Guided, Linac-Based, Surgical Cavity-Hypofractionated Stereotactic Radiotherapy in 5 Daily Fractions for Brain Metastases.

Vellayappan B, Foote M, Redmond KJ, Chao ST, Lo SS.

Neurosurgery. 2019 Nov 1;85(5):E870-E871. doi: 10.1093/neuros/nyz189. No abstract available.

PMID:
31165871
16.

The importance of staying connected: Mediating and moderating effects of social group memberships on psychological well-being after brain tumor.

Cubis L, Ownsworth T, Pinkham MB, Foote M, Legg M, Chambers S.

Psychooncology. 2019 Jul;28(7):1537-1543. doi: 10.1002/pon.5125. Epub 2019 Jun 6.

PMID:
31115102
17.

Unseen Trauma-Our Responsibility to Discover.

Foote MB.

JAMA Intern Med. 2019 May 1;179(5):609. doi: 10.1001/jamainternmed.2019.0234. No abstract available.

PMID:
30907947
18.

Utility of a repeat PET/CT scan in HPV-associated Oropharyngeal Cancer following incomplete nodal response from (chemo)radiotherapy.

Liu HY, Milne R, Lock G, Panizza BJ, Bernard A, Foote M, McGrath M, Brown E, Gandhi M, Porceddu SV.

Oral Oncol. 2019 Jan;88:153-159. doi: 10.1016/j.oraloncology.2018.11.033. Epub 2018 Dec 5.

PMID:
30616786
19.

Proceedings of the 2018 next-generation Gamma Knife research meeting.

Chiang VL, Chao ST, Tuleasca C, Foote MC, Lee CC, Mathieu D, Soliman H, Sahgal A.

J Neurosurg. 2018 Dec 1;129(Suppl1):5-9. doi: 10.3171/2018.7.GKS181206.

PMID:
30544302
20.

Commentary: Stereotactic Body Radiotherapy for Spinal Metastases at the Extreme Ends of the Spine: Imaging-Based Outcomes for Cervical and Sacral Metastases.

Vellayappan B, Tan D, Foote M, Redmond KJ, Lo SS.

Neurosurgery. 2019 Nov 1;85(5):E804-E805. doi: 10.1093/neuros/nyy428. No abstract available.

PMID:
30295828
21.

Radiological Kinetics of Brain Metastases and Clinical Implications for Patients Treated With Stereotactic Radiosurgery.

Nicholls LW, Pinkham MB, Bernard A, Lusk R, Watkins T, Hall B, Olson S, Foote MC.

Clin Oncol (R Coll Radiol). 2019 Jan;31(1):34-40. doi: 10.1016/j.clon.2018.09.005. Epub 2018 Sep 29.

PMID:
30279038
22.

An Ex Vivo Human Tumor Assay Shows Distinct Patterns of EGFR Trafficking in Squamous Cell Carcinoma Correlating to Therapeutic Outcomes.

Joseph SR, Gaffney D, Barry R, Hu L, Banushi B, Wells JW, Lambie D, Strutton G, Porceddu SV, Burmeister B, Leggatt GR, Schaider H, Dolcetti R, Frazer IH, Saunders NA, Foote M, Soyer HP, Simpson F.

J Invest Dermatol. 2019 Jan;139(1):213-223. doi: 10.1016/j.jid.2018.06.190. Epub 2018 Aug 2.

23.

The evolution and rise of stereotactic body radiotherapy (SBRT) for spinal metastases.

Vellayappan BA, Chao ST, Foote M, Guckenberger M, Redmond KJ, Chang EL, Mayr NA, Sahgal A, Lo SS.

Expert Rev Anticancer Ther. 2018 Sep;18(9):887-900. doi: 10.1080/14737140.2018.1493381. Epub 2018 Jul 3. Review.

PMID:
29940802
24.

Pacing of Paleozoic macroevolutionary rates by Milankovitch grand cycles.

Crampton JS, Meyers SR, Cooper RA, Sadler PM, Foote M, Harte D.

Proc Natl Acad Sci U S A. 2018 May 29;115(22):5686-5691. doi: 10.1073/pnas.1714342115. Epub 2018 May 14.

25.

Population description and clinical response assessment for spinal metastases: part 2 of the SPIne response assessment in Neuro-Oncology (SPINO) group report.

Laufer I, Lo SS, Chang EL, Sheehan J, Guckenberger M, Sohn MJ, Ryu S, Foote M, Muacevic A, Soltys SG, Chao S, Myrehaug S, Gerszten PC, Lis E, Maralani P, Bilsky M, Fisher C, Rhines L, Verlaan JJ, Schiff D, Fehlings MG, Ma L, Chang S, Parulekar WR, Vogelbaum MA, Sahgal A.

Neuro Oncol. 2018 Aug 2;20(9):1215-1224. doi: 10.1093/neuonc/noy047.

26.

Intralesional PV-10 for the treatment of in-transit melanoma metastases-Results of a prospective, non-randomized, single center study.

Read TA, Smith A, Thomas J, David M, Foote M, Wagels M, Barbour A, Smithers BM.

J Surg Oncol. 2018 Mar;117(4):579-587. doi: 10.1002/jso.24921. Epub 2018 Mar 12.

27.

Diversity-dependent evolutionary rates in early Palaeozoic zooplankton.

Foote M, Cooper RA, Crampton JS, Sadler PM.

Proc Biol Sci. 2018 Feb 28;285(1873). pii: 20180122. doi: 10.1098/rspb.2018.0122.

28.

In response to Fogarty et al. and why adjuvant whole brain radiotherapy is not recommended routinely.

Pinkham MB, Sahgal A, Pullar AP, Foote MC.

BMC Cancer. 2017 Nov 15;17(1):768. doi: 10.1186/s12885-017-3672-z.

29.

Using "Mystery Patient" Drills to Assess Hospital Ebola Preparedness in New York City, 2014-2015.

Foote M, Daver R, Quinn C.

Health Secur. 2017 Sep/Oct;15(5):500-508. doi: 10.1089/hs.2016.0130. Epub 2017 Sep 22.

PMID:
28937795
30.

Assessment of Hospital Emergency Department Response to Potentially Infectious Diseases Using Unannounced Mystery Patient Drills - New York City, 2016.

Foote MMK, Styles TS, Quinn CL.

MMWR Morb Mortal Wkly Rep. 2017 Sep 15;66(36):945-949. doi: 10.15585/mmwr.mm6636a2.

31.

Postoperative stereotactic radiosurgery for limited brain metastases: are we ready for prime time?

Lo SS, Brown PD, Foote M, Chao ST, Chang EL, Sahgal A.

Expert Rev Anticancer Ther. 2017 Sep;17(9):775-777. doi: 10.1080/14737140.2017.1358090. Epub 2017 Jul 24. No abstract available.

PMID:
28737065
32.

Consider Adjuvant Intensity Modulated Radiation Therapy to the Lymph Node Basin, Especially If the Melanoma Is BRAF Wild Type.

Foote M.

Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):15. doi: 10.1016/j.ijrobp.2016.12.029. No abstract available.

PMID:
28586954
33.

How electronic health records can unmask the hidden value of PAs.

Ogunfiditimi F, Sherry SP, Foote M, Christie SL, Shock LP, Cawley J, Browne A; American Academy of PAs Fee for Value Task Force.

JAAPA. 2017 Jun;30(6):1-3. doi: 10.1097/01.JAA.0000516345.50761.e3.

PMID:
28538436
34.

Vector-model-supported optimization in volumetric-modulated arc stereotactic radiotherapy planning for brain metastasis.

Liu ESF, Wu VWC, Harris B, Foote M, Lehman M, Chan LWC.

Med Dosim. 2017 Summer;42(2):85-89. doi: 10.1016/j.meddos.2017.01.002. Epub 2017 Mar 18.

PMID:
28318935
35.

Stereotactic spine radiosurgery: Review of safety and efficacy with respect to dose and fractionation.

Huo M, Sahgal A, Pryor D, Redmond K, Lo S, Foote M.

Surg Neurol Int. 2017 Feb 20;8:30. doi: 10.4103/2152-7806.200581. eCollection 2017. Review.

36.

Validation of the ICON-S staging for HPV-associated oropharyngeal carcinoma using a pre-defined treatment policy.

Porceddu SV, Milne R, Brown E, Bernard A, Rahbari R, Cartmill B, Foote M, McGrath M, Coward J, Panizza B.

Oral Oncol. 2017 Mar;66:81-86. doi: 10.1016/j.oraloncology.2017.01.002. Epub 2017 Jan 21.

PMID:
28249652
37.

Risk Profiles for Sensorineural Hearing Loss in Patients with Head and Neck Cancer Receiving Cisplatin-based Chemoradiation.

Shorter P, Harden F, Owen R, Panizza B, Burmeister B, Sommerville J, Mengersen K, Foote M.

J Med Imaging Radiat Sci. 2017 Mar;48(1):61-67. doi: 10.1016/j.jmir.2016.11.005. Epub 2016 Dec 26.

PMID:
31047212
38.

Stereotactic Ablative Body Radiotherapy for the Treatment of Spinal Oligometastases.

Chang JH, Gandhidasan S, Finnigan R, Whalley D, Nair R, Herschtal A, Eade T, Kneebone A, Ruben J, Foote M, Siva S.

Clin Oncol (R Coll Radiol). 2017 Jul;29(7):e119-e125. doi: 10.1016/j.clon.2017.02.004. Epub 2017 Feb 23.

PMID:
28237218
39.

Results of a phase II, open-label, non-comparative study of intralesional PV-10 followed by radiotherapy for the treatment of in-transit or metastatic melanoma.

Foote M, Read T, Thomas J, Wagels M, Burmeister B, Smithers BM.

J Surg Oncol. 2017 Jun;115(7):891-897. doi: 10.1002/jso.24580. Epub 2017 Feb 23.

40.

A multinational report of technical factors on stereotactic body radiotherapy for oligometastases.

Redmond KJ, Lo SS, Dagan R, Poon I, Foote MC, Erler D, Lee Y, Lohr F, Biswas T, Ricardi U, Sahgal A.

Future Oncol. 2017 May;13(12):1081-1089. doi: 10.2217/fon-2016-0479. Epub 2017 Feb 3.

PMID:
28152619
41.
42.

Radiotherapy in Glioblastoma: the Past, the Present and the Future.

Gzell C, Back M, Wheeler H, Bailey D, Foote M.

Clin Oncol (R Coll Radiol). 2017 Jan;29(1):15-25. doi: 10.1016/j.clon.2016.09.015. Epub 2016 Oct 13. Review.

PMID:
27743773
43.

Conformal orbit sparing radiation therapy: a treatment option for advanced skin cancer of the parotid and ear region.

Foley H, Hopley S, Brown E, Bernard A, Foote M.

J Med Radiat Sci. 2016 Sep;63(3):186-94. doi: 10.1002/jmrs.161. Epub 2016 Mar 19.

44.

Diagnostic potential of tumor DNA from ovarian cyst fluid.

Wang Y, Sundfeldt K, Mateoiu C, Shih IeM, Kurman RJ, Schaefer J, Silliman N, Kinde I, Springer S, Foote M, Kristjansdottir B, James N, Kinzler KW, Papadopoulos N, Diaz LA, Vogelstein B.

Elife. 2016 Jul 15;5. pii: e15175. doi: 10.7554/eLife.15175.

45.

What has been learned from mouse models of the Fragile X Premutation and Fragile X-associated tremor/ataxia syndrome?

Foote MM, Careaga M, Berman RF.

Clin Neuropsychol. 2016 Aug;30(6):960-72. doi: 10.1080/13854046.2016.1158254. Epub 2016 Jun 29. Review.

46.

Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) Motor Dysfunction Modeled in Mice.

Foote M, Arque G, Berman RF, Santos M.

Cerebellum. 2016 Oct;15(5):611-22. doi: 10.1007/s12311-016-0797-6. Review.

47.

The Role of Postoperative Radiotherapy for Large Nerve Perineural Spread of Cancer of the Head and Neck.

Gorayski P, Foote M, Porceddu S, Poulsen M.

J Neurol Surg B Skull Base. 2016 Apr;77(2):173-81. doi: 10.1055/s-0036-1571839. Epub 2016 Feb 26. Review.

48.

Evaluation of accuracy and reproducibility of a relocatable maxillary fixation system for fractionated intracranial stereotactic radiation therapy.

Russo M, Owen R, Bernard A, Moutrie V, Foote M.

J Med Radiat Sci. 2016 Mar;63(1):41-7. doi: 10.1002/jmrs.142. Epub 2015 Sep 22.

49.

Technical know-how in stereotactic ablative radiotherapy (SABR).

Lo SS, Foote M, Siva S, Slotman BJ, Teh BS, Guckenberger M, Tan D, Mayr NA, Sahgal A.

J Med Radiat Sci. 2016 Mar;63(1):5-8. doi: 10.1002/jmrs.163. Epub 2016 Mar 3.

50.

The High Burden of Cancer Among American Indians/Alaska Natives in Wisconsin.

Foote M, Strickland R, Lucas-Pipkorn S, Williamson A, Lamers L.

WMJ. 2016 Feb;115(1):11-6.

Supplemental Content

Support Center